BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32347057)

  • 1. [Research progress in transdermal delivery for small interfering RNA].
    Chen Y; Xu N; Hu Z
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):622-631. PubMed ID: 32347057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in transdermal siRNAs delivery: A review of current research progress.
    Sufianov A; Beilerli A; Kudriashov V; Ilyasova T; Wenjie B; Beylerli O
    Noncoding RNA Res; 2023 Sep; 8(3):392-400. PubMed ID: 37275244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Topical siRNA Delivery Approaches for Skin Disorders.
    Aldawsari M; Chougule MB; Babu RJ
    Curr Pharm Des; 2015; 21(31):4594-605. PubMed ID: 26362644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Non-viral siRNA Delivery Systems as a Promising Treatment of Skin Diseases.
    Rosa J; Suzuki I; Kravicz M; Caron A; Pupo AV; Praça FG; Bentley MVLB
    Curr Pharm Des; 2018; 24(23):2644-2663. PubMed ID: 30084329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in copolymer-mediated siRNA delivery.
    Wu ZW; Chien CT; Liu CY; Yan JY; Lin SY
    J Drug Target; 2012 Aug; 20(7):551-60. PubMed ID: 22758393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidic systems for in vivo siRNA delivery.
    Wu SY; McMillan NA
    AAPS J; 2009 Dec; 11(4):639-52. PubMed ID: 19757082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances of siRNA delivery by nanoparticles.
    Yuan X; Naguib S; Wu Z
    Expert Opin Drug Deliv; 2011 Apr; 8(4):521-36. PubMed ID: 21413903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous short-interfering RNA therapy.
    Geusens B; Sanders N; Prow T; Van Gele M; Lambert J
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1333-49. PubMed ID: 19941411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study and Evaluation of the Potential of Lipid Nanocarriers for Transdermal Delivery of siRNA.
    Lee K; Min D; Choi Y; Kim J; Yoon S; Jang J; Park S; Tanaka M; Cho YW; Koo HJ; Jeon H; Choi J
    Biotechnol J; 2020 Dec; 15(12):e2000079. PubMed ID: 32678938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylenimine as a promising vector for targeted siRNA delivery.
    Nimesh S
    Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
    Nimesh S
    Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo delivery of siRNA].
    Shi ML; Zhao ZH; Wang Y; Chen HP
    Yi Chuan; 2009 Jul; 31(7):683-8. PubMed ID: 19586872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
    J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in development of siRNA delivery vehicles for cancer therapy.
    Kim HJ; Kim A; Miyata K; Kataoka K
    Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.